Multimodal Detection. DNA, RNA, Antibodies, Antigens, Proteins. One platform. Multiple biomarkers. Meet us at BIO2026 22-25 June on @EUeic pavilion, to learn how this can help point-of-care clinicians, and accelerate drug-discovery, biomarker screening, and remote clinical trials
Altratech Ltd will demo its Unified platform for Multi-Modal Biomarker Detection at BIO2026 in San Diego, 22-25 June 2026, on the EIC @EUeic pavilion. We are pleased to be among 15 EU biotech SME's selected by EIC to present at BIO2026: @Biotechnology_Innovation_Organization.
Altratech Ltd is attending the BARDA Innovation Symposium this week in Washington DC, and MEDICA 2024 next week in Dusseldorf. Look forward to meeting you there! See our novel diagnostic technology at https://t.co/83hC1TNYUi
Looking forward to travelling to #SanDiego next week for @TriConference Meet us at our booth 305, & hear from our CEO Tara Dalton as she presents 'At-Home Next-Generation Molecular Detection with All-Synthetic PNA and CMOS' on Tues 7 Mar.
Find out more: https://t.co/DvJLCxpul1
Tara Dalton, CEO, @AltraTech joins us now at #CapitalSummit22.
Tara will be speaking to us about 'Raising capital for next-generation molecular detection research'
Find out more here: https://t.co/nJ1v0OlFxv
Tara Dalton, CEO, of @AltraTech will join us at #CapitalSummit22 on November 16th, Croke Park Dublin.
Tara will be delivering a spotlight session on "Raising capital for next-generation molecular detection research."
Book your tickets now!: https://t.co/nJ1v0OlFxv